NYSE:MDT - Medtronic Stock Price, News, & Analysis

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

Medtronic declared a quarterly dividend on Friday, August 24th. Shareholders of record on Friday, September 28th will be given a dividend of $0.50 per share on Friday, October 19th. This represents a $2.00 annualized dividend and a yield of 2.16%. The ex-dividend date of this dividend is Thursday, September 27th. View Medtronic's Dividend History.

Medtronic declared that its Board of Directors has authorized a stock buyback program on Thursday, October 5th 2017, which permits the company to repurchase $5,000,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy up to 49% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company's leadership believes its stock is undervalued.

Medtronic PLC (NYSE:MDT) posted its quarterly earnings data on Tuesday, August, 21st. The medical technology company reported $1.17 EPS for the quarter, topping analysts' consensus estimates of $1.11 by $0.06. The medical technology company had revenue of $7.38 billion for the quarter, compared to the consensus estimate of $7.24 billion. Medtronic had a net margin of 10.56% and a return on equity of 12.98%. The business's revenue was down .1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.12 EPS. View Medtronic's Earnings History.

Medtronic is scheduled to release their next quarterly earnings announcement on Tuesday, November 20th 2018. View Earnings Estimates for Medtronic.

Medtronic issued an update on its FY19 earnings guidance on Tuesday, August, 21st. The company provided EPS guidance of $5.10-5.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.11.

20 equities research analysts have issued 12-month price objectives for Medtronic's stock. Their forecasts range from $80.00 to $120.00. On average, they anticipate Medtronic's share price to reach $102.4474 in the next year. This suggests a possible upside of 10.6% from the stock's current price. View Analyst Price Targets for Medtronic.

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last year. There are currently 7 hold ratings, 12 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medtronic.

News coverage about MDT stock has trended negative recently, according to InfoTrie Sentiment. The research group ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Medtronic earned a news impact score of -2.6 on InfoTrie's scale. They also gave news stories about the medical technology company a news buzz of 7.0 out of 10, meaning that recent press coverage is likely to have an impact on the company's share price in the next several days.

Some companies that are related to Medtronic include Varian Medical Systems (VAR), SONOVA Hldg AG/ADR (SONVY), Masimo (MASI), LivaNova (LIVN), GETINGE AB/ADR (GNGBY), CONMED (CNMD), NxStage Medical (NXTM), AxoGen (AXGN), Natus Medical (BABY), Viewray (VRAY), Cutera (CUTR), Electrocore (ECOR), BioLife Solutions (BLFS), Rockwell Medical (RMTI) and Semler Scientific (SMLR).

Medtronic's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.21%), Massachusetts Financial Services Co. MA (4.25%), Bank of New York Mellon Corp (1.26%), Wells Fargo & Company MN (0.94%), American Century Companies Inc. (0.59%) and FMR LLC (0.52%). Company insiders that own Medtronic stock include Bradley E Lerman, Bryan C Hanson, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, Hooman Hakami, James T Lenehan, Michael J Coyle, Omar Ishrak, Richard H Anderson, Richard Kuntz and Robert C Pozen. View Institutional Ownership Trends for Medtronic.

MDT stock was sold by a variety of institutional investors in the last quarter, including Sanders Capital LLC, Massachusetts Financial Services Co. MA, Wells Fargo & Company MN, Bahl & Gaynor Inc., Flossbach Von Storch AG, Prudential Financial Inc., BlackRock Inc. and Wedge Capital Management L L P NC. Company insiders that have sold Medtronic company stock in the last year include Bradley E Lerman, Bryan C Hanson, Carol A Surface, Geoffrey Martha, Hooman Hakami, James T Lenehan, Michael J Coyle and Richard Kuntz. View Insider Buying and Selling for Medtronic.

MDT stock was purchased by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Pendal Group Ltd, American Century Companies Inc., FMR LLC, Alliancebernstein L.P., Atalanta Sosnoff Capital LLC, Adams Diversified Equity Fund Inc. and Skandinaviska Enskilda Banken AB publ. Company insiders that have bought Medtronic stock in the last two years include James T Lenehan, Richard H Anderson and Robert C Pozen. View Insider Buying and Selling for Medtronic.

Shares of MDT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MDT stock can currently be purchased for approximately $92.64.

Medtronic has a market capitalization of $127.43 billion and generates $29.95 billion in revenue each year. The medical technology company earns $3.10 billion in net income (profit) each year or $4.77 on an earnings per share basis. Medtronic employs 86,000 workers across the globe.

The official website for Medtronic is http://www.medtronic.com.

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company can be reached via phone at 353-1438-1700 or via email at [email protected]